✦ LIBER ✦

Treatment of chronic non-A, non-B hepatitis with interferon

✍ Scribed by Karino, Yoshiyasu ;Matsushima, Takashi ;Saga, Akiyoshi ;Tsuyuguchi, Masako ;Miyazaki, Tamotsu ;Toyota, Jouji

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 407 KB
Volume: 26
Category: Article
ISSN: 0435-1339
DOI: 10.1007/bf02779308

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histological improvement of chronic hepa

Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: Application of a numerical scoring system for evaluating sequential morphologic changes

✍ Okuno, Tadao ;Shindo, Michiko ;Arai, Ken ;Matsumoto, Masayuki ;Takeda, Makoto 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 582 KB

Interferon therapy for non-A, non-B chro

Interferon therapy for non-A, non-B chronic hepatitis

✍ Lino, Shiro ;Hino, Kunihiko ;Kondo, Toshiro ;Koike, Kazuhiko ;Yasuda, Kiyomi ;Yo 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 533 KB

Treatment of acute non-A, non-B hepatiti

Treatment of acute non-A, non-B hepatitis with interferon alpha-2b

✍ N. C. Tassopoulos; Maria Koutelou; G. Papatheodoridis; Th. Giannikakis; Melpomen 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 192 KB

Treatment of chronic non-A, non-B hepati

Treatment of chronic non-A, non-B hepatitis with acyclovir: Pilot study

✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot

Interferon and chronic non-A, non-B hepa

Interferon and chronic non-A, non-B hepatitis: Whom are we treating?

✍ Harold O. Conn; Ronald L. Koretz 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Chronic hepatitis C (non-A, non-B hepatitis) is a common and often progressive viral liver diseeee. To aegees the efficacy of therapy with the antiviral agent interferon alfa, we randomly assigned 166 patients with chronic hepatitis C to treatment with either 3 million or 1 million units of recombin

Hepatitis C viraemia rebound after “succ

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non-A, non-B hepatitis

✍ Dr. J. A. Garson; S. Brillanti; C. Ring; P. Perini; M. Miglioli; L. Barbara 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w